Day 1 September 09, 2019 Zurich Opening Ceremony. Keynote Forum

Similar documents
Cancer Diagnosis and Treatment August 02-03, 2018 Oslo, Norway

IMMUNOLOGY. July 26-28, 2018 Moscow, Russia. Allied Academies. Souvenir 11 th Annual Congress on

CARDIOLOGY NUTRITION AND FITNESS. 3rd World Congress on. 16th International Conference on. October 29-30, 2018 London, UK. Allied Academies.

Probiotics, Nutrition and Microbes July 18-19, 2018 Prague, Czech Republic

Vaccines & Vaccination

Tentative Program. ***speaker slots available*** Cancer Science and Targeted Therapies. conferenceseries.com Cancer Therapy 2018

Cancer Therapy B2B Participation. Expert Meet On. November 14-15, 2018 Melbourne, Australia. Cancer Therapy Meeting 2018

BIOMARKERS AND CANCER TARGETS. 15+ Interactive Sessions. 10+ Keynote Lectures. 40+ Scientific Sessions. 3+ Workshops. 30+ Posters.

Scientific Program. Vascular Dementia & 27 th Euro-Global Neurologists Meeting. conferenceseries.com. 11 th International Conference on

International Conference on Breast Cancer December 3-4, 2018 Dubai, UAE

TRADITIONAL MED MEET 2018 TRADITIONAL AND COMPLEMENTARY MEDICINE. Nature Endownment to give us a new dawn of surpassing health

Conference series 47 Churchfield Road, London, W3 6AY, UK

News Letter. Thanks letter AOCC2014. Asian Organization for Crohn s and Colitis. Vol.1 - Issue 1. Dear Colleagues, Dear Participants,

CURRICULUM VITAE. Department of Diagnostic Radiology F Bachelor of Medicine: , China Medical Collage, Taiwan.

NEUROLOGY AND NEUROSCIENCE

2011 International Conference of Inflammation, Cancer and Metabolic Disorders Program

Oncology & Cancer May 06-07, 2019 Tokyo, Japan

Nuclear Medicine and Radiation Therapy. International Conference on. July 16-17, 2018 Madrid, Spain. Nuclear Meetings Medicine 2018.

Johan Garssen, Utrecht University, Netherlands

SUMMARY REPORT OF ACUPUNCTURE SESSION

14:00-14:25 14:25-14:50 14:50-15:15 15:15-15:40

8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina

THE PATIENT VOICE IN CHINA:

Scientific Program. Conference. Colorectal Cancer. 36 th World Cancer. 3 rd Edition of International Conference on

The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer

INTERNATIONAL METABOLIC DISEASES AND LIVER CANCER CONFERENCE 2018

The 8th National Gastric Cancer Academic Conference: focus on specification, translational research, and plan

Cancer: Causes, Diagnosis,Prevention

Residual Cancer. May 3-5, International Symposium. on Minimal. Le Corum. > Preliminary. Program MONTPELLIER, FRANCE

Conference series 47 Churchfield Road, London, W3 6AY, UK

Ready for a CRO That Values Performance Over Promises? CHALLENGE. At Clinipace, it s personal.

Novel EGFR TKI Theliatinib: An Open Label, Dose Escalation Phase I Clinical Trial

* Pre-congress workshop (4 August 2016) * Main programme (5 and 6 August 2016)

Founded in 2016 to develop life-changing therapies against debilitating aggressive cancers that have limited treatment options

CURRICULUM VITAE. Name: PoTsung Chen, Ph.D.

Tentative Program. Epilepsy & Treatment. ***For available speaker slots*** conferenceseries.com. B2B

2014 KASBP Fall Symposium

Overall survival with afatinib versus chemotherapy in patients with NSCLC harboring common EGFR

Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications

Therapy - Minimize harm to patients

Conducting Successful Oncology Clinical Trials in Asia Pacific: PharmaNet experience using Case Studies

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine

BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES. Overview and Mechanism of Action Dr.

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

microrna Therapeutics Heading Towards the Clinic

T E N T A T I V E P R O G R A M

Momentous gathering of the dental industry DenTech China 2017 The 21 st China International Exhibition & Symposium on Dental Equipment, Technology &

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

2 nd International Oncologist & Diagnostics Conference

Curriculum Vitae. 2002/ /12 PhD, The Institute of Basic Medical Sciences, Medical College, National Cheng Kung University, Tainan, Taiwan

HBSN Annual Report (2016) Editorial Office

World Eye and Vision Congress. September 06-08, 2018 Dubai, Uae

Biology Based Cancer Interception

Appendix F: Test-Curriculum Matching Analysis

BioPlex 2200 Infectious Disease Panels

2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme

Recommended composition of influenza virus vaccines for use in the influenza season

ICGC launches new project and releases more genomic data on cancer

The 5th Congress of Asian Society of Cardiovascular Imaging

Global EHS Resource Center

Tobacco: World Markets and Trade

OBSTETRICS AND GYNECOLOGY June 21-23, 2018 London, UK

B I ABOUT BI DISEASE AREA & MECHANISM OF ACTION. For journalists outside UK/US/Canada only B A C K G R O U N D E R

Novel MOAs and targets for cancer drug development What s hot off the presses?

Traditional & Alternative Medicine

CURRICULUM VITAE. Employment Experience Distinguished Professor, Department of Pubic Finance, National Cheng-Chi University

Liver Cancer Screening in Korea: A Report on the 2008 National Cancer Screening Programme

17:00 17:45 Meet-the-Professor Immuno-Oncology Fan Yang, Beijing, Christoph Zielinski, Vienna

TGH Annual Report (2016) Editorial Office

Press Room M0E: Vienna International Centre, Vienna, Austria MONDAY, 11 FEBRUARY 2013 (DAY 1)

CCO Annual Report (2016) Editorial Office

OMICS Journals are welcoming Submissions

Engineered Immune Cells for Cancer Therapy : Current Status and Prospects

A Summary of Childhood Cancer Statistics in Australia,

For personal use only

Tentative Program. Metabolic and Bariatric Surgery. ***For available speaker slots*** conferenceseries.com.

Nephrology Urology Renal care

St. Gallen 2011 Symposium Highlights in China

USE OF EXOSOMES IN TRANSLATIONAL AND CLINICAL RESEARCH. Eva Colás Ortega Postdoc researcher IRBLleida

APOPC 2018 Programme

Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP. thus showing therapeutic potential in colorectal carcinoma

Demands and Perspectives of Hadron Therapy

Nutraceuticals & Natural Medicine October 22-23, 2018 Amsterdam, Netherlands

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

EV-based Clinical Theranostics

How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

Circulating tumor cells/dna/etc for Radiation Oncologists

Annual Flash Report (unaudited) Fiscal Year ended March 31, 2017

The Test-Curriculum Matching Analysis: Science

NGR-TNF selectively binds to tumor blood vessels via CD13, inducing the activation of caspases and promoting apoptotic endothelial cell death in vivo

World Cancer Summit 2018

Fourth Symposium on Phospholipids in Pharmaceutical Research. 21 st 22 nd, September 2015 Heidelberg, Germany. 3rd Circular

Viral hepatitis and Hepatocellular Carcinoma

WORLD VACCINE MEET 2018 WORLD CONFERENCE ON VACCINE AND IMMUNOLOGY

Final Program. 9 th Georg Rajka ISAD Program - Thursday, May 19, 2016 at the Renaissance São Paulo Hotel Theater

15+ Interactive Sessions. 10+ Keynote Lectures. 40+ Scientific Sessions. 3+ Workshops. 30+ Posters. B2B Meetings

Transcription:

09:00-09:30 09:30-10:15 10:15-11:00 Day 1 September 09, 2019 Zurich Opening Ceremony Keynote Forum Title: Novel molecules trapped into biocompatible drug delivery systems direct to solid tumors Dr. Carmela Saturnino,University of Basilicata, Italy Title: Onnetsu-Invisible Oncology Dr.Kazuko Tatsumura Director, Gaia Holistic Health, USA Group Photo Networking & Refreshments Break 11:00-11:15 @ Foyer Cancer Cell Biology l Cancer Biomarkers l Cancer Vaccines Chair : Dr. Heike Pohla, Munich Unversity Hospitals,Germany Co Chair : Dr.Robert Watson, National Cancer Research Institute,UK 11:15-11:50 11:50-12:25 14:00-14:35 14:35-15:10 15:30-16:00 16:00-16:30 16:30-17:00 Title: Identification and validation of HLA-A24 XBP1, CD138, and CS1 peptides and induction of antigensspecific CD8+ T cell immunity using a multipeptide cocktail: preclinical basis for vaccine therapy in HLA-A24 patients with multiple myeloma and other cancers Prof.Jooeun Bae, Dana-Farber Cancer Institute, USA Title: Mesenchymal stem cells in inflammatory microenvironment promotes cancer cell migration and epithelial-mesenchymal transition through osteopontin Dr. Heike Pohla Head of the Tumor Immunology Laboratory,Munich University Hospital,Germany Lunch Break 13:00-14:00@ Title: Validation of a Novel Therapeutic Target for Targeted Radionuclide-Antibody Therapy of Malignant Pleural Effusion Jaecheong Lim, Korea Atomic Energy Research Institute, Republic of Korea Title: Brazilian natural compound FLAV5: A promising anticancer drug Giovanna Barbarini Longato, University of San Francisco, USA Networking & Refreshments Break: 15:10-15:30 @ Young Researchers Forum Title: High expression of Pyruvate Dehydrogenase Kinase in Cholangiocarcinoma patients Divya Ram Jayram, Ben-Gurien University of Negev,Isreal Title: Serum apurinic/apyrimidinic endodeoxyribonuclease 1 in cholangiocarcinoma patients Doungdean Tummanatsakun, Khon Kaen University, Thailand Title: High expression of Pyruvate Dehydrogenase Kinase in Cholangiocarcinoma patients Daraporn Chua-on, Khon Kaen University, Japan Panel Discussion

Day 2 September 10, 2019 Kagayaki Keynote Forum 10:00-10:45 10:45-11:30 11:45-12:20 Title: MicroRNA expression in advanced breast cancer Stefan Glueck Professor of Medicine,Celgene Corporation,USA Title: mirnacancermap: A web server prioritizing tumor associated mirna Prof.Dr.P.H.Krammer, German Cancer Research Center,Germany Chair : Lei Huo, University of Texas, USA Co Chair : Jiangwen Zhang, The University of Hong Kong, Hong Kong SAR Cancer Treatment and Therapeutics l Cancer Research Networking & Refreshments Break 11:30-11:45@ Foyer Title: Sphk2 inhibitor ABC294640 enhances cell death in NSCLC cells via downregulation and proteasomedependent degradation of c-flipl Mr.Daniel Vitale, The University of Sydney,Australia 12:20-12:55 Title: The potential of circulating tumor cells (CTCs) in personalized management of breast cancer: A systematic review Fatemeh Khatami, University of Medical Sciences, Spain GCC 01 GCC 02 GCC 03 GCC 04 GCC 05 GCC 06 GCC 07 Lunch Break 12:55-13:55@ 1F Restaurant the Café Poster Presentation 14:00-16:00 Title: Targeted CT contrast agents for molecular imaging of cancer based on cathepsins' elevated activity Darya Tsvirkun, The Hebrew University, Israel Title: Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles Dr.Romina Rosch,German Cancer Research Center,Germany Title: Development of bacterial glucuronidase specific inhibitors to reduce chemo-induced intestinal toxicity and diarrhea Jaunting Haung,University of Beijing, China Title: Optimizations of anti-peg sandwich ELISA for quantification of PEGylated molecules Ming-yang Tseng, Kaohsiung Medical University, Taiwan Title: Optimization of an anti-poly(ethylene glycol) (anti-peg) cell-based capture system to quantify PEG and PEGylated molecules Wen-Wei Lin, National Sun Yat-sen University, Taiwan Title: Acetylated mangostin alleviates many anticancer effects of mangostin at the molecular levels Han-Heom Na, Kangwon National University, Republic of Korea Keun-Cheol Kim, Kangwon National University, Republic of Korea Title: ERK regulates liver cirrhosis and hepatocellular carcinoma

GCC 08 GCC 09 Abeer Muhanna, Saudi Cancer Research Center, Saudi Arabia Title: Snail-induced claudin-11 engenders collective migration and forms circulating tumor cell clusters to promote tumor progression Miss. Mary Alexandra, Blokhin Russian Cancer Research Centre,Russia Title: Apoptotic effect of Prunus spinosa fruit extract on HT-29 colon cancer cell line Egzona Qipa, Trakya University, Turkey Networking & Refreshments Break: 15:00-15:30 @ Foyer Poster Evalution Award Ceremony Networking and Lunch @ 12.00-13:00 1F Restaurant the Café Our Collabrators:

Our Media Partners: